Inhibition of Human Eosinophil Activation by a Cysteinyl Leukotriene Receptor Antagonist (Pranlukast; ONO-1078)

References

• Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000; 105: 651–663
   PubMed Web of Science ®Google Scholar
• Busse WW, Lemanske RF., Jr. Advances in immunology: asthma. N Engl J Med 2001; 344(5)350–362
   PubMed Web of Science ®Google Scholar
• Leiferman KM. A role for eosinophils in atopic dermatitis. J Am Acad Dermatol 2001; 45(1 Pt 2)S21–S24
   Google Scholar
• Kurtzhals JA, Reimert CM, Tette E, Dunyo SK, Koram KA, Akanmori BD, Nkrumah FK, Hviid L. Increased eosinophil activity in acute plasmodium falciparum infection-association with cerebral malaria. Clin Exp Immunol 1998; 112(2)303–307
   PubMedGoogle Scholar
• Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356: 2144–2148
   PubMed Web of Science ®Google Scholar
• Kato M, Abraham RT, Okada S, Kita H. Ligation of the β2 integrin triggers activation and degranulation of human eosinophils. Am J Respir Cell Mol Biol 1998; 18: 675–686
   PubMed Web of Science ®Google Scholar
• Horiguchi T, Tachikawa S, Kasahara J, Doi M, Shiga M. Effects of pranlukast hydrate on serum eosinophil cationic protein levels in patients with adult bronchial asthma. Arzneimittelforschung 1999; 49(1)35–37
   PubMedGoogle Scholar
• Bartemes KR, McKinney S, Gleich GJ, Kita H. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG. J Immunol 1999; 162: 2982–2989
   PubMedGoogle Scholar
• Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999; 54: 825–857
   PubMed Web of Science ®Google Scholar
• Leff AR. Role leukotrienes in bronchial hyperresponsiveness and cellular responses in airways. Thorax 2000; 55: S32–S37
   PubMed Web of Science ®Google Scholar
• Lee E, Robertson T, Smith J, Kilfeatfer S. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am J Respir Cell Mol Biol 2000; 161: 1881–1886
   Google Scholar
• Figueroa DJ, Breyer RM, Defoe SK, Kargman S, Daugherty BL, Waldburger K, Liu Q, Clements M, Zeng Z, O'Neill GP, Jones TR, Lynch KR, Austin CP, Evans JF. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Cell Mol Biol 2001; 163: 226–233
   Google Scholar
• Nakagawa N, Obata T, Kobayashi T, Okada Y, Nambu F, Terasaki T, Furuya T, Muryobayashi K, Sawada M, Aishita H. Effect of a peptide leukotriene receptor antagonist, ONO-1078, on Guinea-pig models of asthma. Eur J Pharmacol 1993; 235(2–3)211–219
   PubMedGoogle Scholar
• Obata T, Okada Y, Motoishi M, Nakagawa N, Terawaki T, Aishita H. In vitro antagonism of ONO-1078, a newly developed anti-asthma agent against peptide leukotrienes in isolated guinea pig tissues. Japan J Pharmacol 1992; 60: 227–237
   PubMedGoogle Scholar
• Yamaguchi T, Kohrogi H, Honda I, Kawano O, Sugimoto M, Araki S, Ando M. A novel leukotrien antagonist, ONO-1078, inhibits and reverses human bronchial contraction induced by leukotriens C4 and D4 and antigen in vitro. Am Rev Respir Dis 1992; 146: 923–929
   PubMed Web of Science ®Google Scholar
• Obata T, Kobayashi T, Okada Y, Nakagawa N, Terawaki T, Aishita H. Effect of a peptide leukotriene antagonist, ONO-1078 on antigen-induced airway microvascular leakage in actively sensitized guinea pigs. Life Sci 1992; 51: 1577–1583
   PubMedGoogle Scholar
• Tohda Y, Nakahara H, Kubo H, Haraguchi R, Fukuoka M, Nakajima S. Effects of ONO-1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma. Clin Exp Allergy 1999; 29: 1532–1536
   PubMed Web of Science ®Google Scholar
• Yoshida S, Ishizaki Y, Shoji T, Onuma K, Nakagawa H, Nakabayashi M, Akahori K, Hasegawa H, Amayasu H. Effect of pranlukast on bronchial inflammation in patients with asthma. Clin Exp Allergy 2000; 30: 1008–1014
   PubMed Web of Science ®Google Scholar
• Sorkness CA. Leuktoriene receptor antagonists in the treatment of asthma. Review Pharmacotherapy 2001; 21(3 pt 2)34S–37S
   Google Scholar
• Korenblat PE. The antileukotriene working group. The role of antileukotrienes in the treatment of asthma. Ann Allergy Asthma Immunol 2001; 86(6 suppl 1)31–39
   PubMedGoogle Scholar
• Wymann MP, Kernen P, von Tscharner V, Tai PC, Spry CJ, Baggiolini M. Activation of the respiratory burst in eosinophil leukocytes—A transduction sequence decoupled from cytosolic Ca2+ rise. Eur J Clin Invest 1995; 25: 25–31
   PubMedGoogle Scholar
• Dent G, Munoz NM, Zhu X, Ruhlmann E, Magnussen H, Leff AR, Rabe KF. Involvement of protein tyrosine kinases in activation of human eosinophils by platelet-activating factor. Immunology 2000; 100(2)231–237
   PubMedGoogle Scholar
• Bandeira-Melo C, Phoofolo M, Weller PF. Extracellular lipid bodies elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leukotriene C4 production in eosinophils and basophils. J Biol Chem 2001; 276: 22779–22787
   PubMed Web of Science ®Google Scholar
• Zhu X, Sano H, Kim KP, Sano A, Boetticher E, Munoz NM, Cho W, Leff AR. Role of mitogen-activated protein kinase-mediated cytosolic phospholipase A2 activation in arachidonic acid metabolism in human eosinophils. J Immunol 2001; 167: 461–468
   PubMed Web of Science ®Google Scholar
• Ide M, Weiler D, Kita H, Gleich GJ. Ammonium chloride exposure inhibits cytokine-mediated eosinophil survival. J Immunol Methods 1994; 168: 187–196
   PubMedGoogle Scholar
• Kaneko M, Horie S, Kato M, Gleich GJ, Kita H. A crucial role for β2 integrin in the activation of eosinophils stimulated by IgG. J Immunol 1995; 155: 2631–2641
   PubMed Web of Science ®Google Scholar
• Horie S, Kita H. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte–macrophage colony-stimulating factor and platelet-activating factor. J Immunol 1994; 152: 5457–5467
   PubMed Web of Science ®Google Scholar
• Virchow JC., Jr., Faehndrich S, Nassenstein C, Bock S, Matthy H, Luttmann W. Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. Clin Exp Allergy 2001; 31(6)836–844
   PubMedGoogle Scholar
• Laviolette M, Ferland C, Comtois JF, Champagne K, Bosse M, Boulet LP. Blood eosinophil leukotriene C4 production in asthma of different severities. Eur Respir J 1995; 8: 1465–1472
   PubMed Web of Science ®Google Scholar
• Shaw RJ, Cromwell O, Kay AB. Preferential generation of leukotriene C4 by human eosinophils. Clin Exp Immunol 1984; 56: 716–722
   PubMed Web of Science ®Google Scholar
• Wenzel SE. Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy 1997; 17(1 Pt 2)3S–12S
   Google Scholar
• Kodani M, Sakata N, Takano Y, Kamiya H, Katsuragi T, Hugli TE, Abe M. Intratracheal administration of anaphylatoxin C5a potentiates antigen-induced pulmonary reactions through the prolonged production of cysteinyl-leukotrienes. Immunopharmacology 2000; 49: 263–274
   PubMed Web of Science ®Google Scholar
• Hisada T, Salmon M, Nasuhara Y, Chung KF. Cysteinyl-leukotrienes partly mediate eotaxin-induced bronchial hyperresponsiveness and eosinophilia in IL-5 transgenic mice. Am J Crit Care Med 1999; 160(2)571–575
   Google Scholar
• Brown E, Hogg N. Where the outside meets inside: integrins as activators and targets of signal transduction cascades. Review Immunol Lett 1996; 54(2–3)189–193
   PubMedGoogle Scholar
• Hynes RO. Integrins: versatility modulation and signaling in cell adhesion. Cell 1992; 69: 1–25
   PubMedGoogle Scholar
• Lub M, van Kooyk Y, Figdor CG. Ins and outs of LFA-1. Review Immunol Today 1995; 16: 479–483
   PubMedGoogle Scholar
• Hogg N, Harvey J, Cabanas C, Landis RC. Control of leukocyte integrin activation. Review Am Rev Respir Dis 1993; 148(6 Pt 2)S55–S59
   Google Scholar
• Longhurst CM, Jennings LK. Integrin-mediated signal transduction. Review Cell Mol Life Sci 1998; 54(6)514–526
   PubMedGoogle Scholar
• Kargman S, Ali A, Vaillancourt JP, Evans JF, Nicholson DW. Protein kinase C-dependent regulation of sulfidopeptide leukotriene biosynthesis and leukotriene C4 synthase in neutrophilic HL-60 cells. Mol Pharmacol 1994; 45(5)1043–1049
   PubMedGoogle Scholar
• Ali A, Ford-Hutchinson AW, Nicholson DW. Activation of protein kinase C down-regulates leukotriene C4 synthase activity and attenuates cysteinyl leukotriene production in an eosinophilic substrain of HL-60 cells. J Immunol 1994; 153(2)776–788
   PubMedGoogle Scholar
• Tamura N, Agrawal DK, Townley RG. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation. J Immunol 1988; 141(12)4291–4297
   PubMedGoogle Scholar
• Kobayashi S, Yoshida K, Mori A, Sugiyama H, Suko M, Okudaira H, Ito K, Inokuma S, Matsumura Y. [Inhibitory effect of ONO-1078, a novel leukotriene receptor antagonist on human peripheral blood eosinophils.]. Arerugi 1996; 45(11)1166–1171
   PubMedGoogle Scholar